These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 32719217)

  • 1. Candidaemia in a tertiary care centre of developing country: Monitoring possible change in spectrum of agents and antifungal susceptibility.
    Kaur H; Singh S; Rudramurthy SM; Ghosh AK; Jayashree M; Narayana Y; Ray P; Chakrabarti A
    Indian J Med Microbiol; 2020; 38(1):110-116. PubMed ID: 32719217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology of candidemia in Qatar, the Middle East: performance of MALDI-TOF MS for the identification of Candida species, species distribution, outcome, and susceptibility pattern.
    Taj-Aldeen SJ; Kolecka A; Boesten R; Alolaqi A; Almaslamani M; Chandra P; Meis JF; Boekhout T
    Infection; 2014 Apr; 42(2):393-404. PubMed ID: 24352810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology of candidemia in Shiraz, southern Iran: A prospective multicenter study (2016-2018).
    Arastehfar A; Yazdanpanah S; Bakhtiari M; Fang W; Pan W; Mahmoudi S; Pakshir K; Daneshnia F; Boekhout T; Ilkit M; Perlin DS; Zomorodian K; Zand F
    Med Mycol; 2021 May; 59(5):422-430. PubMed ID: 32692816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Candida tropicalis is the most prevalent yeast species causing candidemia in Algeria: the urgent need for antifungal stewardship and infection control measures.
    Megri Y; Arastehfar A; Boekhout T; Daneshnia F; Hörtnagl C; Sartori B; Hafez A; Pan W; Lass-Flörl C; Hamrioui B
    Antimicrob Resist Infect Control; 2020 Apr; 9(1):50. PubMed ID: 32264966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology and reporting of candidaemia in Belgium: a multi-centre study.
    Trouvé C; Blot S; Hayette MP; Jonckheere S; Patteet S; Rodriguez-Villalobos H; Symoens F; Van Wijngaerden E; Lagrou K
    Eur J Clin Microbiol Infect Dis; 2017 Apr; 36(4):649-655. PubMed ID: 27858242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Five-year profile of candidaemia at an Indian trauma centre: High rates of Candida auris blood stream infections.
    Mathur P; Hasan F; Singh PK; Malhotra R; Walia K; Chowdhary A
    Mycoses; 2018 Sep; 61(9):674-680. PubMed ID: 29738604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changing epidemiology of candidaemia in Australia.
    Chapman B; Slavin M; Marriott D; Halliday C; Kidd S; Arthur I; Bak N; Heath CH; Kennedy K; Morrissey CO; Sorrell TC; van Hal S; Keighley C; Goeman E; Underwood N; Hajkowicz K; Hofmeyr A; Leung M; Macesic N; Botes J; Blyth C; Cooley L; George CR; Kalukottege P; Kesson A; McMullan B; Baird R; Robson J; Korman TM; Pendle S; Weeks K; Liu E; Cheong E; Chen S;
    J Antimicrob Chemother; 2017 Apr; 72(4):1103-1108. PubMed ID: 28364558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increase in candidemia cases and emergence of fluconazole-resistant
    Siopi M; Georgiou PC; Paranos P; Beredaki MI; Tarpatzi A; Kalogeropoulou E; Damianidou S; Vasilakopoulou A; Karakosta P; Pournaras S; Meletiadis J
    Euro Surveill; 2024 Jul; 29(29):. PubMed ID: 39027938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Candida species distribution and antifungal susceptibility testing according to European Committee on Antimicrobial Susceptibility Testing and new vs. old Clinical and Laboratory Standards Institute clinical breakpoints: a 6-year prospective candidaemia survey from the fungal infection network of Switzerland.
    Orasch C; Marchetti O; Garbino J; Schrenzel J; Zimmerli S; Mühlethaler K; Pfyffer G; Ruef C; Fehr J; Zbinden R; Calandra T; Bille J;
    Clin Microbiol Infect; 2014 Jul; 20(7):698-705. PubMed ID: 24188136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiological features of nosocomial candidaemia in neonates, infants and children: A multicentre study in Iran.
    Ahangarkani F; Shokohi T; Rezai MS; Ilkit M; Mahmoodi Nesheli H; Karami H; Tamaddoni A; Alizadeh-Navaei R; Khodavaisy S; Meis JF; Badali H
    Mycoses; 2020 Apr; 63(4):382-394. PubMed ID: 31985076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Candidaemia in haematological malignancy patients from a SEIFEM study: Epidemiological patterns according to antifungal prophylaxis.
    Posteraro B; De Carolis E; Criscuolo M; Ballanti S; De Angelis G; Del Principe MI; Delia M; Fracchiolla N; Marchesi F; Nadali G; Picardi M; Piccioni AL; Verga L; Candoni A; Busca A; Sanguinetti M; Pagano L;
    Mycoses; 2020 Sep; 63(9):900-910. PubMed ID: 32531854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of bloodstream Candida species in a Spanish tertiary care hospital as a guide for implementation of T2MR (T2CANDIDA®) for rapid diagnosis of candidemia.
    Falces-Romero I; Romero-Gómez MP; Moreno-Ramos F; Mingorance J; García-Rodríguez J; Cendejas-Bueno E
    Med Mycol; 2021 Apr; 59(4):350-354. PubMed ID: 32634233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study of Candida spp. isolates: Identification and echinocandin susceptibility in isolates obtained from blood cultures in 15 hospitals in Medellín, Colombia.
    Berrio I; Maldonado N; De Bedout C; Arango K; Cano LE; Valencia Y; Jiménez-Ortigosa C; Perlin DS; Gómez BL; Robledo C; Robledo J;
    J Glob Antimicrob Resist; 2018 Jun; 13():254-260. PubMed ID: 29183771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Candidaemia due to Candida parapsilosis species complex at a hospital in Brazil: Clinical characteristics and antifungal susceptibility profile.
    Alencar DSO; Tsujisaki RAS; Spositto FLE; Nunes MO; Almeida AA; Martins MDA; Melhem MSC; Chang MR
    Rev Iberoam Micol; 2017; 34(2):106-108. PubMed ID: 28214273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antifungal resistance in patients with Candidaemia: a retrospective cohort study.
    Aldardeer NF; Albar H; Al-Attas M; Eldali A; Qutub M; Hassanien A; Alraddadi B
    BMC Infect Dis; 2020 Jan; 20(1):55. PubMed ID: 31952505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of Candida blood stream infections: experience of a tertiary care centre in North India.
    Chander J; Singla N; Sidhu SK; Gombar S
    J Infect Dev Ctries; 2013 Sep; 7(9):670-5. PubMed ID: 24042103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First multicentre report of in vitro resistance rates in candidaemia isolates in Turkey.
    Arikan-Akdagli S; Gülmez D; Doğan Ö; Çerikçioğlu N; Doluca Dereli M; Birinci A; Yıldıran ŞT; Ener B; Öz Y; Metin DY; Hilmioğlu-Polat S; Kalkancı A; Koç N; Erturan Z; Fındık D
    J Glob Antimicrob Resist; 2019 Sep; 18():230-234. PubMed ID: 30980958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proof of Concept for MBT ASTRA, a Rapid Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry (MALDI-TOF MS)-Based Method To Detect Caspofungin Resistance in Candida albicans and Candida glabrata.
    Vatanshenassan M; Boekhout T; Lass-Flörl C; Lackner M; Schubert S; Kostrzewa M; Sparbier K
    J Clin Microbiol; 2018 Sep; 56(9):. PubMed ID: 30021820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigating Antifungal Susceptibility in
    Delavy M; Dos Santos AR; Heiman CM; Coste AT
    Front Cell Infect Microbiol; 2019; 9():19. PubMed ID: 30792970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.